Cray Falde is a seasoned professional in the pharmaceutical sales industry, currently serving as a Key Account Manager at Averitas Pharma since September 2021, specializing in medical procedure accounts and the Qutenza topical system. Previous experience includes roles at Lundbeck as a Biopharmaceutical Account Manager, where Falde contributed to the launch of Vyepti and achieved notable rankings in volume growth. Falde's background also encompasses a Senior Specialty Representative position at Amgen, and several leadership roles at Peet's Coffee, Sucampo Pharma Americas, Novo Nordisk, and Biovail. Cray Falde holds a Bachelor of Science in Business Education from Ashland University.